文献速递骨显像与常规 SPECT核素与放射性配体治疗

90Y放射滑膜切除术治疗膝关节置换后持续性滑膜炎的长期结局

90Y Radiosynovectomy in Persistent Synovitis Caused by Knee Replacement: Long-Term Outcome.
PubMed 文献 · Clin Nucl Med · 2021-01-01

该队列研究纳入55例患者共57个膝关节置换后持续性滑膜炎的膝关节,行90Y-枸橼酸放射滑膜切除术(RSO),剂量为4.9 ± 0.24 mCi(182 ± 9 MBq),RSO次数1至4次。长期随访显示27%优效、24%良好、30%弱效、20%无效,缓解持续12.0 ± 12.0个月(最长54个月);重复治疗者在末次RSO后3个月与单次治疗者效果相似,长期随访结束时重复治疗者效果更高。

要点

  • RSO对膝关节置换后持续性滑膜炎的长期有效率较高(优效27%、良好24%)。
  • 缓解持续时间平均12.0 ± 12.0个月,最长54个月。
  • 重复RSO在长期随访时效果优于单次治疗,且骨扫描65%患者摄取减少。

核心结论

  • RSO是膝关节置换后持续性滑膜炎的有效疗法,长期反应率高。
  • 重复治疗可带来更强的长期反应。

研究设计与样本

  • 队列研究,纳入55例患者共57个膝关节置换后持续性滑膜炎的膝关节。
  • RSO使用4.9 ± 0.24 mCi(182 ± 9 MBq)的90Y-枸橼酸,次数1至4次。
  • 每次RSO前及后3个月行骨扫描,长期随访0.8至7.6年,平均23.2个月。

主要发现

  • 长期反应:优效27%、良好24%、弱效30%、无效20%。
  • 缓解持续时间12.0 ± 12.0个月,最长54个月。
  • 重复治疗者首次治疗后效果低于单次治疗者,但末次RSO后3个月效果相似。
  • 长期随访结束时,重复RSO者在相似缓解持续时间下效果更高。
  • 骨扫描显示65%患者摄取减少;主观与客观反应一致者占78%。

关键数值与推荐

  • 定性分析采用已建立的4级评分法。

临床怎么用

  • 对膝关节置换后持续性滑膜炎患者,可考虑90Y-RSO治疗。
  • 重复RSO可能增强长期疗效,但需结合个体情况评估。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: After knee replacement, therapy resistant, persistent synovitis is a common issue, which causes effusion and pain, and leads to loosing. It has been hypothesized that radiosynovectomy (RSO) is useful in these patients. MATERIALS AND METHODS: A cohort of 55 patients with 57 knee replacements and persistent synovitis underwent RSO using 4.9 ± 0.24 mCi (182 ± 9 MBq) of Y-citrate. The number of RSOs ranged from 1 to 4. Bone scans before and 3 months after every RSO were performed. Long-term follow-up ranged from 0.8 to 7.6 years with a mean of 23.2 months. For qualitative analysis, an established 4 steps scoring was used. For quantification, the uptake was determined within the Tc-MDP scintigraphy blood pool phase before and after therapy. RESULTS: Long-term response was in 27% with excellent, 24% good, 30% weak, and 20% no response. The duration of response was 12.0 ± 12.0 months (maximum, 54 months). In patients with repeated treatment, the effect after the first therapy was lesser than in patients who received a single treatment in total. However, 3 months after the last RSO, patients with repeated treatment showed a similar effectiveness than single treated patients. At the end of long-term follow-up, patients with repeated RSOs had a higher effectiveness at similar duration response. In bone scan, 65% of patients showed a reduction of uptake. When comparing subjective and objective response, 78% of patients showed a concordance in both symptoms and scintigraphy. Pilot histological analysis revealed that the synovitis is triggered by small plastic particles. CONCLUSIONS: We concluded that RSO is an effective therapy in patients with knee replacement and persistent synovitis with high long-term response. Repeated treatment leads to a stronger long-time response.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Liepe K, Baehr M. 90Y Radiosynovectomy in Persistent Synovitis Caused by Knee Replacement: Long-Term Outcome. Clin Nucl Med. 2021. PMID: 33234919. doi:10.1097/RLU.0000000000003405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。